4//SEC Filing
Burton Paul 4
Accession 0001127602-22-025107
CIK 0001682852other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:08 PM ET
Size
8.7 KB
Accession
0001127602-22-025107
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Burton Paul
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-11-04+402→ 1,146 total - Exercise/Conversion
Restricted Stock Units
2022-11-04−402→ 4,427 totalExercise: $0.00From: 2022-08-05→ Common Stock (402 underlying) - Sale
Common Stock
2022-11-07$158.68/sh−192$30,467→ 954 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]25% of the shares subject to this restricted stock unit award vested on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001869869
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:08 PM ET
- Size
- 8.7 KB